The House would cut FDA funding next year under a bill approved by a subcommittee last week.
Fiscal 2013 FDA appropriations bills moving through Congress suggest a similar pattern to the prior two years, where a conference committee will likely need to resolve differences between a Senate seeking to increase FDA appropriations and a House version that would reduce funding.
The appropriations bill was approved by the House Agriculture, Rural Development, Food and Drug Administration and Related Agencies Subcommittee June 6. It calls for $2.48 billion in direct appropriations to...
The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.
Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.
Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.
